Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Shanghai Heartcare Medical Technology Corp. Ltd. Class H (6609) Stock Price & Analysis

2 Followers

6609 Stock Chart & Stats

HK$47.74-HK$1.22(-2.49%)
At close: 4:00 PM GMT+8
HK$45HK$50HK$55HK$60Aug 10Aug 24Sep 7Sep 21Oct 5Oct 20Nov 2
Day’s Range
HKD 47.40 - HKD 51.15
52-Week Range
HKD 35.00 - HKD 66.90
Previous Close
HKD 48.96
Volume
N/A
Average Volume (3M)
46.18K
Market Cap
HKD 2.01B
Enterprise Value
HKD 664.27M
Total Cash (Recent Filing)
HKD 789.70M
Total Debt (Recent Filing)
HKD 41.22M
Price to Earnings (P/E)
16.4
Beta
0.84
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Expansion

Revenue has expanded dramatically over several years, indicating meaningful commercial scaling and broader adoption of the company’s cardiovascular intervention products. This larger operating base can support greater efficiency, customer reach, and reinvestment capacity over the next several quarters.

Improved Profitability

The sharp 2025 margin improvement shows that revenue growth is translating into positive operating and net income rather than remaining purely top-line expansion. If retained, stronger margins can create durable internal funding, improve resilience, and strengthen the economics of future growth.

Low Leverage And Positive Cash Flow

A lightly leveraged balance sheet combined with positive operating and free cash flow gives the company meaningful financial flexibility. This supports product investment and working-capital needs while reducing dependence on external financing and limiting the burden of interest costs.

Bears Say

Profitability Volatility

The recent profit inflection has not yet established a consistent multi-year earnings record. Losses as recently as 2024 mean future results remain sensitive to execution and operating conditions, making the sustainability of the current margin structure an important fundamental risk.

Variable Cash Conversion

The move to positive cash generation is encouraging, but the preceding negative years show that cash conversion has varied materially across periods. Until positive operating and free cash flow persist, funding for expansion may remain less predictable and could constrain capital allocation.

Recently Rebuilt Returns

Positive returns are a recent development rather than a long-established characteristic of the business. Historical losses have absorbed equity value, while future reinvestment needs could still pressure returns, leaving the company’s ability to compound capital dependent on sustained execution.

Shanghai Heartcare Medical Technology Corp. Ltd. Class H News

6609 FAQ

What was Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s price range in the past 12 months?
Shanghai Heartcare Medical Technology Corp. Ltd. Class H lowest stock price was HK$35.00 and its highest was HK$66.90 in the past 12 months.
What is Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s market cap?
Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s market cap is HK$2.01B.
When is Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s earnings last quarter?
Shanghai Heartcare Medical Technology Corp. Ltd. Class H released its earnings results on Aug 31, 2026. The company reported HK$1.875 earnings per share for the quarter.
Is Shanghai Heartcare Medical Technology Corp. Ltd. Class H overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Shanghai Heartcare Medical Technology Corp. Ltd. Class H pay dividends?
Shanghai Heartcare Medical Technology Corp. Ltd. Class H does not currently pay dividends.
What is Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s EPS estimate?
Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shanghai Heartcare Medical Technology Corp. Ltd. Class H have?
Shanghai Heartcare Medical Technology Corp. Ltd. Class H has 31,565,804 shares outstanding.
What happened to Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s price movement after its last earnings report?
Shanghai Heartcare Medical Technology Corp. Ltd. Class H reported an EPS of HK$1.875 in its last earnings report. Following the earnings report the stock price went up 2.653%.
Which hedge fund is a major shareholder of Shanghai Heartcare Medical Technology Corp. Ltd. Class H?
Currently, no hedge funds are holding shares in HK:6609
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology